Search

Your search keyword '"Corixa Corp. -- Cases"' showing total 7 results
Start Over Descriptor "Corixa Corp. -- Cases"
7 results on '"Corixa Corp. -- Cases"'

1. Idec scores big win in patent lawsuit: judge rules that area firm didn't infringe on patent of rival

Subjects
San Diego County, California -- Economic aspects, IDEC Pharmaceuticals Corp. -- Cases, IDEC Pharmaceuticals Corp. -- Product information, Corixa Corp. -- Cases, Vaccines industry, Biological products industry, Company legal issue, Business, Business, regional
Abstract

San Diego-based Idec Pharmaceuticals Corp. scored a big win when a judge ruled that its Seattle-based rival, Corixa Corp., and partners can't use four patents to block sales of Idec's [...]

Published
2003

2. business briefs

Subjects
GlaxoSmithKline PLC -- Cases, Corixa Corp. -- Cases, Exxon Mobil Corp. -- Cases, Terrorism -- Finance, Terrorism -- Cases, Racism -- Cases, Prisoners -- Cases, Pharmaceutical industry -- Cases, Patent infringement -- Cases, Gambling -- Cases, Energy industry -- Cases, Damages -- Cases, Company financing, Company legal issue, Business, general, Government, Law, News, opinion and commentary
Published
2004

3. RULING FAVORS IDEC IN PATENT DISPUTE WITH 2 RIVALS

Subjects
Company legal issue, Patent/copyright issue, GlaxoSmithKline Inc. (Research Triangle Park, North Carolina) -- Cases, Corixa Corp. -- Cases, IDEC Pharmaceuticals Corp. -- Cases, Biological products industry -- Cases, Copyright -- Cases, Patents -- Cases, Pharmaceutical industry -- Cases
Abstract

Idec Pharmaceuticals said yesterday that a federal judge in California had ruled in its favor in a two-year patent dispute with two drug makers, Corixa and GlaxoSmithKline, over Idec's cancer […]

Published
2003

5. US court denies Biogen Idec's motion against Corixa's Bexxar patent

Subjects
Biogen Idec Inc. -- Cases, Corixa Corp. -- Cases, Biotechnology industry -- Cases, Vaccines industry -- Cases, Company legal issue, Pharmaceuticals and cosmetics industries
Abstract

Corixa has said that the US District Court, Southern District of California, has vacated its October 14, 2003 grant of Biogen Idec's motion for summary judgment in which Bexxar (tositumomab) [...]

Published
2004

6. Corixa, GSK, Biogen Idec settle dispute

Subjects
Corixa Corp. -- Cases, GlaxoSmithKline PLC -- Cases, Biogen Idec Inc. -- Cases, Patent infringement -- Cases, Biological products industry -- Cases, Pharmaceutical industry -- Cases, Vaccines industry -- Cases, Company legal issue, Biotechnology industry, Bexxar (Medication) -- Cases, Zevalin (Medication) -- Cases
Abstract

Ending a dispute over cancer therapy patents, Corixa Corp. and GlaxoSmithKline plc settled all outstanding lawsuits with Cambridge, Mass.-based Biogen Idec Inc. At issue were patent infringement claims on the [...]

Published
2004

7. FDA grants Corixa's appeal on Bexxar hearing

Subjects
United States. Food and Drug Administration -- Cases, Corixa Corp. -- Cases, Vaccines industry -- Cases, Cancer -- Drug therapy, Biotechnology industry
Abstract

Corixa Corp. won an appeal against an FDA decision issued earlier This year that required additional clinical trials in order to market the cancer drug Bexxar. While biotechnology analysts cautioned [...]

Published
2002

Catalog

Books, media, physical & digital resources
See catalog results